Seizures in Pregnancy/Eclampsia

Emergency Medicine Clinics of North America

Volumn 29, Issue 1, 2011, Pages 109-116

  Stead, Latha Ganti ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

Eclampsia; Pre eclampsia; Pregnancy; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; DIAZOXIDE; DIURETIC AGENT; HYDRALAZINE; KETANSERIN; LABETALOL; MAGNESIUM SULFATE; NITROPRUSSIDE SODIUM; PHENYTOIN; PLACEBO;

ANTICONVULSANT ACTIVITY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BOLUS INJECTION; CESAREAN SECTION; DEEP TENDON REFLEX; DISEASE CONTROL; DISTRIBUTION VOLUME; DIZZINESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; DRUG OVERDOSE; DRUG PROTEIN BINDING; ECLAMPSIA; EMERGENCY WARD; EMOTIONAL STRESS; FIRST TRIMESTER PREGNANCY; FLUSHING; GESTATIONAL AGE; HEART PALPITATION; HUMAN; HYPOTENSION; KIDNEY FAILURE; LABORATORY TEST; MATERNAL HYPERTENSION; MATERNAL MORTALITY; NAUSEA; NAUSEA AND VOMITING; NEWBORN MORTALITY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PLACENTA PERFUSION; PLASMA VOLUME; PLASMA VOLUME EXPANSION; PNEUMONIA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; PUERPERIUM; REPEATED DRUG DOSE; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; RISK REDUCTION; SCALP PRURITUS; SEIZURE; SIDE EFFECT; TENDON REFLEX; TERATOGENICITY;

EID: 78649427968     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2010.09.005     Document Type: Review

References (24)

1. Holmes L.B., Harvey E.A., Coull B.A., et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001, 344(15):1132-1138.
2. Tatum W.O. Balancing the risks to the fetus from epileptic seizures and antiepileptic drug exposure in pregnancy. Expert Rev Neurother 2009, 9(12):1707-1708.
3. ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996. Committee on educational bulletins of the American college of obstetricians and gynecologists. Int J Gynaecol Obstet 1997, 56(3):279-286.
4. Yerby M.S., Friel P.N., McCormick K., et al. Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Res 1990, 5(3):223-228.
5. Schmidt D., Beck-Mannagetta G., Janz D., et al. The effect of pregnancy on the course of epilepsy: a prospective study. Epilepsy, pregnancy, and the child 1982, 39-49. Raven Press, New York. D. Janz, M. Dam, A. Richens (Eds.).
6. Vajda F.J., Hitchcock A., Graham J., et al. Seizure control in antiepileptic drug-treated pregnancy. Epilepsia 2008, 49(1):172-176.
7. Geographic variation in the incidence of hypertension in pregnancy. World Health Organization international collaborative study of hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988, 158(1):80-83.
8. Duley L., Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2003, 4. CD000128.
9. Duley L., Gulmezoglu A.M., Henderson-Smart D.J. Magnesium sulphate and other anticonvulsants for women with preeclampsia. Cochrane Database Syst Rev 2003, 2. CD000025.
10. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000, 183(1):S1-22.
11. Duley L., Henderson-Smart D. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006, 3. CD001449.
12. Duley L., Williams J., Henderson-Smart D. Plasma volume expansion for treatment of pre-eclampsia. Cochrane Database Syst Rev 1999, 4. CD001805. Updated 2010.
13. Churchiil D., Beevers G.D.C., Meher S., et al. Diuretics for preventing preeclampsia. Cochrane Database Syst Rev 2007, 1. CD004451.
14. Odendaal H.J., Pattinson R.C., Bam R., et al. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990, 76(6):1070-1075.
15. Sibai B.M., Mercer B.M., Schiff E., et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994, 171(3):818-822.
16. Knight M., Duley L., Henderson-Smart D., et al. Antiplatelet agents for preventing and treating preeclampsia. Cochrane Database Syst Rev 2007, 2. CD004659.
17. Rubold A., Duley L., Crowther C.A., et al. Antioxidants for preventing and treating pre-eclampsia. Cochrane Database Syst Rev 2008, 1. CD004227.
18. Li W., Tang L., Wu T., et al. Chinese herbal medicines for treating pre-eclampsia. Cochrane Database Syst Rev 2006, 2. CD005126.
19. Meher S., Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007, 2. CD006490.
20. Meher S., Duley L. Progesterone for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2006, 4. CD006175.
21. Meher S., Duley L. Rest during pregnancy for preventing preeclampsia and its complications in women with normal blood pressure. Cochrane Database Syst Rev 2006, 2. CD005939.
22. Meher S., Duley L. Exercise or other physical activity for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2006, 2. CD005942.
23. Meher S., Duley L. Garlic for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2006, 3. CD006065.
24. Duley L., Henderson-Smart D.J., Meher S. Altered dietary salt for preventing preeclampsia, and its complications. Cochrane Database Syst Rev 2005, 4. CD005548.